Low Fructose Diet in Diabetes Type 2
Primary Purpose
Fructose Metabolism Disorder
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
low frutose diet
Sponsored by
About this trial
This is an interventional supportive care trial for Fructose Metabolism Disorder
Eligibility Criteria
Inclusion Criteria:
- Age of 70-40 years
- body mass index(BMI) between 18.5 and 27
- Type 2 diabetes People who only control their diabetes by using glucose lowering tablets Type 2 diabetes (1 to 10 years)
Exclusion Criteria:
- Pregnancy and lactation
- Thyroid gland disorders
- Kidney disease and inflammation
- Follow the weight loss regimen 6 months before starting the study
- Usage of fatty and fatty foods, fiber powder Vitamin A Mineral Supplements, Omega 3
- Taking glucocorticoid drugs and non-steroidal anti-inflammatory drugs
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
intervention group
control group
Arm Description
Eight weeks of low fructose diet with a maximum of 12 g of fructose
Eight weeks of regular diabetic diet with a 15%pro 30%fat 55%CHO
Outcomes
Primary Outcome Measures
fasting blood suger(FBS)
Homeostatic model assessment and insulin resistance(HOMA-IR)
insulin
Secondary Outcome Measures
Triglyceride
Total cholestrole
LDL-C
HDL-C
Blood pressure
Full Information
NCT ID
NCT03352596
First Posted
November 13, 2017
Last Updated
November 20, 2017
Sponsor
National Nutrition and Food Technology Institute
1. Study Identification
Unique Protocol Identification Number
NCT03352596
Brief Title
Low Fructose Diet in Diabetes Type 2
Official Title
Effects of Low Fructose Diet on Glycemic Control in Patients With Type 2 Diabetes
Study Type
Interventional
2. Study Status
Record Verification Date
August 2017
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2017 (Actual)
Primary Completion Date
October 1, 2017 (Actual)
Study Completion Date
November 30, 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Nutrition and Food Technology Institute
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Diabetes is one of the most common and chronic diseases in the world, with the prevalence and incidence of this disease rising in most societies, especially in Iran. Suitable treatments for type 2 diabetes include changing lifestyle with exercise, nutrition, and drug use. New research suggests that added sugar, especially fructose, is the main trigger for diabetes and pre-diabetes even more potent than other carbohydrates. Fructose has a low glycemic index (23μg =) and slowly increases blood glucose levels. Therefore, it is thought that replacing fructose instead of glucose can have a positive effect on glycemic control of diabetic patients..
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fructose Metabolism Disorder
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
48 (Actual)
8. Arms, Groups, and Interventions
Arm Title
intervention group
Arm Type
Experimental
Arm Description
Eight weeks of low fructose diet with a maximum of 12 g of fructose
Arm Title
control group
Arm Type
No Intervention
Arm Description
Eight weeks of regular diabetic diet with a 15%pro 30%fat 55%CHO
Intervention Type
Other
Intervention Name(s)
low frutose diet
Primary Outcome Measure Information:
Title
fasting blood suger(FBS)
Time Frame
8 weeks
Title
Homeostatic model assessment and insulin resistance(HOMA-IR)
Time Frame
8weeks
Title
insulin
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Triglyceride
Time Frame
8 weeks
Title
Total cholestrole
Time Frame
8 weeks
Title
LDL-C
Time Frame
8 weeks
Title
HDL-C
Time Frame
8 weeks
Title
Blood pressure
Time Frame
8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age of 70-40 years
body mass index(BMI) between 18.5 and 27
Type 2 diabetes People who only control their diabetes by using glucose lowering tablets Type 2 diabetes (1 to 10 years)
Exclusion Criteria:
Pregnancy and lactation
Thyroid gland disorders
Kidney disease and inflammation
Follow the weight loss regimen 6 months before starting the study
Usage of fatty and fatty foods, fiber powder Vitamin A Mineral Supplements, Omega 3
Taking glucocorticoid drugs and non-steroidal anti-inflammatory drugs
12. IPD Sharing Statement
Learn more about this trial
Low Fructose Diet in Diabetes Type 2
We'll reach out to this number within 24 hrs